Medco Finance Limited

Medco Finance Limited is a financial services firm registered in the United Kingdom, incorporated on 8 February 2023. The company lists its official website as medcofinance.vip, though its registered address is given as Sweetwood Drive Street, Boulder, Colorado 80302 in the United States—a discrepancy between its UK registration and US address.

Independent public information about Medco Finance Limited is extremely limited. The broker does not appear to have an established reputation or track record in the industry. As of our review, there are no independent user reviews or third-party analyses available, making it difficult to verify the firm's operations or claims.

According to our records, Medco Finance Limited holds no regulatory licenses from any financial authority. The absence of regulation is a significant concern, as it means the broker is not subject to oversight by a recognized regulatory body such as the FCA (UK), CySEC, or ASIC.

Traders should be aware that unregulated brokers offer no recourse to compensation schemes or dispute resolution services in the event of misconduct. The lack of regulatory information on the broker's website also raises questions about transparency and client fund protection.

Medco Finance Limited offers a range of account tiers designed to cater to different investor profiles. The available accounts are: GOLD (minimum deposit €200,000), PREMIUM (minimum deposit €100,000), INVESTOR (minimum deposit €20,000), SILVER (minimum deposit €2,500), and BEGINNER (minimum deposit €100).

All account types list the maximum leverage as two dashes ('--'), which likely indicates that leverage information is not disclosed or is variable. The wide range in minimum deposits suggests the broker aims to attract both retail clients with small capital and high-net-worth individuals, though the high-tier accounts require substantial investment.

The known facts do not specify the financial instruments offered by Medco Finance Limited. Similarly, no information is available regarding trading platforms (such as MetaTrader 4/5 or proprietary software). This lack of clarity makes it impossible to assess the broker's trading environment, available markets, or execution technology.

Prospective clients are advised to seek detailed information directly from the broker, though due diligence is challenging given the absence of verifiable operational data.

Medco Finance Limited has been assigned a Scam Risk Score of 49 out of 100 by FXCanary, indicating a 'Guarded' risk level. This score reflects the broker's recent registration (less than two years old), lack of regulation, and limited public footprint.

The discrepancy between the UK registration and the US address is noteworthy and may indicate a shell company or misleading corporate structure. Without regulatory oversight, clients have minimal protection and may face risks related to fund security, trade execution, and transparency.